Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data

Christoph Lübbert, Igor Dykukha, Jann-Patrick Pelz, Helen Yearley, Wolfgang Junker, Nina Gruber, Sibyll Escher, Katrin Biereth, Sima Melnik, Julia Puschmann

Article Type

Review

Published

This article aimed to assess the prevalence of individuals with one or more risk factors for severe COVID-19 along with contraindications and potential drug–drug interactions due to ritonavir-containing COVID-19 therapy.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.